Syndax Pharmaceuticals Inc.
SNDX | NASDAQ
$18.14
+$0.07 (+0.39%)
Sep 22, 2026, 11:18 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -6.39 | -3.54 | -7.25 | -10.35 | 45.60 | -12.56 |
PEG Ratio | 0.54 | -0.14 | -0.34 | 0.02 | -0.36 | 3.30 |
PS Ratio | 10.56 | 47.80 | n/a | n/a | 8.16 | 605.60 |
PB Ratio | 28.16 | 3.93 | 2.74 | 3.31 | 2.79 | 3.64 |
P/FCF Ratio | -5.63 | -4.12 | -9.47 | -11.55 | 39.30 | -12.89 |
P/OCF Ratio | -5.64 | -4.12 | -9.47 | -11.57 | 39.12 | -12.89 |
OCF/S Ratio | -187.40 | -1.16K | n/a | n/a | 20.85 | -4.7K |
Debt / Equity Ratio | 5.36 | 1.20 | 0 | 0 | 0.05 | 0.08 |
Quick Ratio | 4.12 | 5.82 | 10 | 16.85 | 21.68 | 15.84 |
Current Ratio | 4.40 | 5.82 | 10 | 16.85 | 21.68 | 15.84 |
Asset Turnover | 0.33 | 0.03 | n/a | n/a | 0.31 | 0.01 |
Interest Coverage | -8.08 | -68.91 | -1.11K | -48.38 | 13.81 | -30.30 |
Return on Equity | -441.62% | -110.63% | -37.78% | -31.95% | 6.10% | -28.97% |
Return on Assets | -53.88% | -43.98% | -34.16% | -30.03% | 5.54% | -24.31% |
Return on Invested Capital | -66.60% | -53.59% | -41.37% | -32.38% | 6.11% | -25.12% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 95.96% | 96.51% | n/a | n/a | 100% | 100% |
Net Profit Margin | -165.60% | -1.35K% | n/a | n/a | 17.84% | -4.82K% |
Pretax Profit Margin | -165.60% | -1.35K% | n/a | n/a | 17.84% | -4.82K% |
Operating Profit Margin | -158.45% | -1.43K% | n/a | n/a | 18.77% | -4.71K% |
FCF Margin | -187.50% | -1.16K% | n/a | n/a | 20.76% | -4.7K% |
EBITDA Margin | -146% | -1.33K% | n/a | n/a | 19.23% | -4.63K% |
Add to Watchlist
Select watchlists to add or remove SNDX